1. Home
  2. ALDX vs BLDE Comparison

ALDX vs BLDE Comparison

Compare ALDX & BLDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • BLDE
  • Stock Information
  • Founded
  • ALDX 2004
  • BLDE 2014
  • Country
  • ALDX United States
  • BLDE United States
  • Employees
  • ALDX N/A
  • BLDE N/A
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • BLDE Aerospace
  • Sector
  • ALDX Health Care
  • BLDE Consumer Discretionary
  • Exchange
  • ALDX Nasdaq
  • BLDE Nasdaq
  • Market Cap
  • ALDX 304.9M
  • BLDE 276.7M
  • IPO Year
  • ALDX 2014
  • BLDE N/A
  • Fundamental
  • Price
  • ALDX $5.40
  • BLDE $3.96
  • Analyst Decision
  • ALDX Strong Buy
  • BLDE Buy
  • Analyst Count
  • ALDX 2
  • BLDE 1
  • Target Price
  • ALDX $10.00
  • BLDE $6.00
  • AVG Volume (30 Days)
  • ALDX 394.0K
  • BLDE 900.1K
  • Earning Date
  • ALDX 03-06-2025
  • BLDE 03-11-2025
  • Dividend Yield
  • ALDX N/A
  • BLDE N/A
  • EPS Growth
  • ALDX N/A
  • BLDE N/A
  • EPS
  • ALDX N/A
  • BLDE N/A
  • Revenue
  • ALDX N/A
  • BLDE $241,814,000.00
  • Revenue This Year
  • ALDX N/A
  • BLDE $11.34
  • Revenue Next Year
  • ALDX N/A
  • BLDE $5.73
  • P/E Ratio
  • ALDX N/A
  • BLDE N/A
  • Revenue Growth
  • ALDX N/A
  • BLDE 12.04
  • 52 Week Low
  • ALDX $2.71
  • BLDE $2.45
  • 52 Week High
  • ALDX $6.55
  • BLDE $5.17
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 60.04
  • BLDE 47.25
  • Support Level
  • ALDX $4.95
  • BLDE $3.78
  • Resistance Level
  • ALDX $5.10
  • BLDE $4.29
  • Average True Range (ATR)
  • ALDX 0.24
  • BLDE 0.25
  • MACD
  • ALDX 0.04
  • BLDE -0.03
  • Stochastic Oscillator
  • ALDX 85.06
  • BLDE 61.63

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.

About BLDE Blade Air Mobility Inc.

Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.

Share on Social Networks: